Gene · 51135
Papers3,419
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,701 to 1,720 of 3,419
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Analysis of Differentially Expressed Genes in Coronary Artery Disease by Integrated Microarray Analysis. | Biomolecules | 2019 | 31881747 | PubTator, text mining | PubMed |
| Microtubules are necessary for proper Reticulon localization during mitosis. | PLoS One | 2019 | 31877164 | PubTator, text mining | PubMed |
| A Structurally-Validated Multiple Sequence Alignment of 497 Human Protein Kinase Domains. | Sci Rep | 2019 | 31875044 | PubTator, text mining | PubMed |
| Mycobacterium tuberculosis Requires Cholesterol Oxidase to Disrupt TLR2 Signalling in Human Macrophages. | Mediators Inflamm | 2019 | 31871425 | PubTator, text mining | PubMed |
| Effects of the Toll-like receptor 7 (TLR7) agonist, AZD8848, on allergen-induced responses in patients with mild asthma: a double-blind, randomised, parallel-group study. | Respir Res | 2019 | 31856838 | PubTator, text mining | PubMed |
Rho-associated kinase and zipper-interacting protein kinase, but not myosin light chain kinase, are involved in the regulation of myosin phosphorylation in serum-stimulated human arterial smooth muscle cells. | PLoS One | 2019 | 31834925 | PubTator, text mining | PubMed |
| Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles. | EPMA J | 2019 | 31832112 | PubTator, text mining | PubMed |
| The Role of Toll-Like Receptors in Skin Host Defense, Psoriasis, and Atopic Dermatitis. | J Immunol Res | 2019 | 31815151 | PubTator, text mining | PubMed |
| Review on Cross Talk between Neurotransmitters and Neuroinflammation in Striatum and Cerebellum in the Mediation of Motor Behaviour. | Biomed Res Int | 2019 | 31815123 | PubTator, text mining | PubMed |
| Ameliorating effects of Gö6976, a pharmacological agent that inhibits protein kinase D, on collagen-induced arthritis. | PLoS One | 2019 | 31809526 | PubTator, text mining | PubMed |
| Co-Delivery Of Dihydroartemisinin And HMGB1 siRNA By TAT-Modified Cationic Liposomes Through The TLR4 Signaling Pathway For Treatment Of Lupus Nephritis. | Int J Nanomedicine | 2019 | 31806961 | PubTator, text mining | PubMed |
Safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06650833, a selective interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor, in single and multiple ascending dose randomized phase 1 studies in healthy subjects. | Arthritis Res Ther | 2019 | 31805989 | PubTator, text mining | PubMed |
| TRIM8 is required for virus-induced IFN response in human plasmacytoid dendritic cells. | Sci Adv | 2019 | 31799391 | PubTator, text mining | PubMed |
| Targeting the Innate Immune Kinase IRAK1 in Radioresistant Cancer: Double-Edged Sword or One-Two Punch? | Front Oncol | 2019 | 31799178 | PubTator, text mining | PubMed |
| IL-33/IL-31 Axis in Immune-Mediated and Allergic Diseases. | Int J Mol Sci | 2019 | 31766607 | PubTator, text mining | PubMed |
| Mutations in Splicing Factor Genes in Myeloid Malignancies: Significance and Impact on Clinical Features. | Cancers (Basel) | 2019 | 31766606 | PubTator, text mining | PubMed |
| Spatial organization of endometrial gene expression at the onset of embryo attachment in pigs. | BMC Genomics | 2019 | 31752681 | PubTator, text mining | PubMed |
| Epigenetic modifications of histones in cancer. | Genome Biol | 2019 | 31747960 | PubTator, text mining | PubMed |
| Interferon target-gene expression and epigenomic signatures in health and disease. | Nat Immunol | 2019 | 31745335 | PubTator, text mining | PubMed |
| Innate Immunity and Alcohol. | J Clin Med | 2019 | 31739600 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51135/papers?page=86